Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Traveling young injection drug users at high risk for acquisition and transmission of viral infections.

Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):43-50. Epub 2007 Nov 5.

2.

Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).

Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR.

J Urban Health. 2003 Mar;80(1):137-46.

3.

Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K.

Addiction. 2010 Jul;105(7):1254-64. doi: 10.1111/j.1360-0443.2010.02949.x. Epub 2010 May 14.

4.
5.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group.

MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

6.

Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors.

Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):143-9. doi: 10.1016/j.drugalcdep.2012.06.024. Epub 2012 Jul 20.

8.

Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.

Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, Latkin C, Celentano DD.

AIDS Care. 2009 Jan;21(1):7-16. doi: 10.1080/09540120802017610.

9.

Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.

Ruan Y, Qin G, Yin L, Chen K, Qian HZ, Hao C, Liang S, Zhu J, Xing H, Hong K, Shao Y.

AIDS. 2007 Dec;21 Suppl 8:S39-46. doi: 10.1097/01.aids.0000304695.54884.4f.

PMID:
18172390
10.

Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.

AIDS. 1996 Mar;10(3):311-7.

PMID:
8882671
11.

Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics.

Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn JA.

J Urban Health. 2013 Jun;90(3):500-15. doi: 10.1007/s11524-012-9718-2.

12.

Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.

Evans JL, Morris MD, Yu M, Page K, Hahn JA.

Drug Alcohol Depend. 2014 Sep 1;142:239-44. doi: 10.1016/j.drugalcdep.2014.06.028. Epub 2014 Jul 4.

13.

[Factors associated with sharing syringes among street-recruited injecting drug users].

Folch C, Meroño M, Casabona J.

Med Clin (Barc). 2006 Oct 14;127(14):526-32. Spanish.

PMID:
17145000
14.

Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.

Shapatava E, Nelson KE, Tsertsvadze T, del Rio C.

Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8.

PMID:
16769443
15.

Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA.

PLoS One. 2014 Oct 6;9(10):e109282. doi: 10.1371/journal.pone.0109282. eCollection 2014.

16.

Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.

Kim NJ, Jin H, McFarland W, Raymond HF.

Int J Drug Policy. 2015 Dec;26(12):1238-43. doi: 10.1016/j.drugpo.2015.08.013. Epub 2015 Aug 22.

PMID:
26365768
17.

Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.

Maher L, Chant K, Jalaludin B, Sargent P.

J Gastroenterol Hepatol. 2004 Oct;19(10):1114-20.

PMID:
15377287
18.

Gender differences in injection risk behaviors at the first injection episode.

Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):145-52. Epub 2007 Feb 5.

PMID:
17276623
19.

Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.

Rhodes T, Hunter GM, Stimson GV, Donoghoe MC, Noble A, Parry J, Chalmers C.

Addiction. 1996 Oct;91(10):1457-67.

PMID:
8917914
20.

Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco.

Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR.

J Viral Hepat. 2008 Mar;15(3):229-36. doi: 10.1111/j.1365-2893.2007.00933.x.

PMID:
18233994

Supplemental Content

Support Center